It is important for the research on breast cancer
and almost daily new discoveries emerge. One important piece of information that will directly affect one in four women diagnosed with breast cancer is Herceptin, which is highly effective in the treatment of breast cancer.

Herceptin is used to promote the benefits of chemotherapy and surgery, and now say that it is used, reduce the risk of cancer recurrence and overall health.

Herceptin is a drug that is highly effective in the treatment of early breast cancer. It is specifically targeted against specific receptors in the body that exacerbates the cancer yet. Approximately 25% of patients have tumors that are diagnosed with HER2 +, this is a receiver in the body called factor receptor human epidermal growth factor-2. HER2 +
tend to grow and metastasize more rapidly than others. Herceptin is particularly effective in the treatment of HER + tumors. Herceptin is used to reduce the risk of distant metastasis of the disease in nearly 50%, which reduces a phenomenal rate of decline in the risk of cancer.

Breast cancer HER2 + is very aggressive and so it is important to find out the status of their HER2 breast cancer. This helps to medical treatments, which may be the right thing for you.

Each cell of the breast, which is normal, in fact, contains a copy of the HER2 gene, which is something that can grow normal cells. The gene is found in DNA, which contains the information for the production of the HER2 protein.

Also known as HER2, the HER2 receptor is also found on the surface of some normal cells. The HER2 protein sends signals from outside to inside the cell to grow and divide.

In breast cancer is HER2 + cancer cells have an unusually high number of HER2 genes in each cell. This extra HER2 protein appears on the surface of cancer cells as well as adding to the rapid growth and multiplication of cancer cells. This is why breast cancer HER2 + is usually very aggressive.

Women who were with Herceptin during or after chemotherapy and surgery show notable improvements. The drug also reduces the chance of developing breast cancer in the other breast. During a long period showed that treatment with Herceptin has dramatically reduced the recurrence of breast cancer.

Experts now think that Herceptin should be included as standard therapy for the treatment of breast cancer, unless there is some specific reason. Even for those with breast cancer early stage, Herceptin is now an important treatment option.